MedTrace Logo

Prognostic Biomarkers of Pancreatic Cancer Based on Proteomic Techniques

NCT05289895 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 220

Last updated 2022-03-22

No results posted yet for this study

Summary

Sequence I (Retrospective study: proteomic analysis of pathological specimens and information collection of previous patients with pancreatic cancer) Sequence 2 (Non-interventional prospective study, sample and information collection in patients with pancreatic cancer) Sequence 3 (Non-intervention study, healthy subjects sample and information collection)

Conditions

Interventions

OTHER

No intervention

This study was an observational trial without any intervention

Sponsors & Collaborators

  • The Affiliated Hospital of Qingdao University

    lead OTHER

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-01
Primary Completion
2023-03-01
Completion
2024-12-30

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05289895 on ClinicalTrials.gov